Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huseyin Akilli

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 6, 2020
Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancerAli Ayhan, Huseyin Akilli
Archives of Gynecology and Obstetrics|October 14, 2018
The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?Ali Ayhan, Huseyin Akilli, Nihan Haberal
Case Reports in Surgery|November 14, 2013
Large conization and laparoendoscopic single-port pelvic lymphadenectomy in early-stage cervical cancer for fertility preservationPolat Dursun, Mete Caglar, Huseyin Akilli, et al.
Journal of Surgical Oncology|October 20, 2022
Hyperthermic intraperitoneal chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom?Ali Ayhan, Huseyin Akilli, Mehmet Ali Abasiyanik, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival PerspectiveAydan Farzaliyeva, Huseyin Akilli, Ozden Altundag, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2020
Risk factors for sexual dysfunction in pregnant women during the COVID-19 pandemicLatife A Karakas, Asli Azemi, Seda Y Simsek, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 9, 2022
Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre studyHuseyin Akilli, Samed Rahatli, Khayala Aliyeva, et al.
Journal of Gynecology Obstetrics and Human Reproduction|May 16, 2020
The Role of Analysis of NK Cell Subsets in Peripheral Blood and Uterine Lavage Samples in Evaluation of Patients with Recurrent Implantation FailureYusuf Aytac Tohma, Ugur Musabak, Emre Gunakan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 6, 2019
Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancerHuseyin Akilli, Samed Rahatli, Yusuf Aytac Tohma, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 26, 2021
Complications of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: An evaluation of 100 casesHuseyin Akilli, Emre Gunakan, Ali Haberal, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 6, 2020
Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancerAli Ayhan, Huseyin Akilli
Archives of Gynecology and Obstetrics|October 14, 2018
The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?Ali Ayhan, Huseyin Akilli, Nihan Haberal
Case Reports in Surgery|November 14, 2013
Large conization and laparoendoscopic single-port pelvic lymphadenectomy in early-stage cervical cancer for fertility preservationPolat Dursun, Mete Caglar, Huseyin Akilli, et al.
Journal of Surgical Oncology|October 20, 2022
Hyperthermic intraperitoneal chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom?Ali Ayhan, Huseyin Akilli, Mehmet Ali Abasiyanik, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival PerspectiveAydan Farzaliyeva, Huseyin Akilli, Ozden Altundag, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2020
Risk factors for sexual dysfunction in pregnant women during the COVID-19 pandemicLatife A Karakas, Asli Azemi, Seda Y Simsek, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 9, 2022
Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre studyHuseyin Akilli, Samed Rahatli, Khayala Aliyeva, et al.
Journal of Gynecology Obstetrics and Human Reproduction|May 16, 2020
The Role of Analysis of NK Cell Subsets in Peripheral Blood and Uterine Lavage Samples in Evaluation of Patients with Recurrent Implantation FailureYusuf Aytac Tohma, Ugur Musabak, Emre Gunakan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 6, 2019
Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancerHuseyin Akilli, Samed Rahatli, Yusuf Aytac Tohma, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 26, 2021
Complications of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: An evaluation of 100 casesHuseyin Akilli, Emre Gunakan, Ali Haberal, et al.
Pageof 3